购物车
- 全部删除
- 您的购物车当前为空
Anti-CD39 Antibody (5S815) 是一种 Rabbit 抗体,靶向 CD39。Anti-CD39 Antibody (5S815) 可用于 ELISA。
Anti-CD39 Antibody (5S815) 是一种 Rabbit 抗体,靶向 CD39。Anti-CD39 Antibody (5S815) 可用于 ELISA。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
100 μL | ¥ 2,294 | 5日内发货 |
产品描述 | Anti-CD39 Antibody (5S815) is a Rabbit antibody targeting CD39. Anti-CD39 Antibody (5S815) can be used in ELISA. |
Ig Type | Monoclonal Rabbit IgG |
克隆号 | 5S815 |
交叉反应 | Mouse |
应用 | ELISA |
推荐剂量 | ELISA: 1:5000-1:10000 |
抗体种类 | Monoclonal |
宿主来源 | Rabbit |
构建方式 | This antibody was obtained from a rabbit immunized with purified, recombinant Mouse CD39 (TMPY-02808; P55772; Thr38-Ile478). |
纯化方式 | Protein A |
性状 | Liquid |
缓冲液 | 0.2 μm filtered solution in PBS |
研究背景 | CD39, also known as ENTPD1, belongs to the GDA1/CD39 NTPase family. It is expressed primarily on activated lymphoid cells and can also be detected in endothelial tissues. The vascular isoform and the placental isoform II are present in both placenta and umbilical vein, whereas placental isoform I is present in placenta only. CD39 can hydrolyze both nucleoside triphosphates and diphosphates. It is the dominant ecto nucleotidase of vascular and placental trophoblastic tissues and appears to modulate the functional expression of type 2 purinergic (P2) G protein coupled receptors (GPCRs). CD39 transgenic mice exhibit impaired platelet aggregation, prolonged bleeding times, and resistance to systemic thromboembolism. There is a correlation between ATP hydrolysis and triglycerides in patients with chronic heart disease, suggesting a relationship between ATP diphosphohydrolase and thrombogenesis. In the nervous system, CD39 could hydrolyze ATP and other nucleotides to regulate purinergic neurotransmission. |
偶联 | Unconjugated |
免疫原 | Recombinant Mouse CD39 protein (TMPY-02808) |
抗原种属 | Mouse |
研究领域 | Phosphatases and Regulators |
储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
运输方式 | Shipping with blue ice. |
评论内容